Filter
364
Filtered Results: 364
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
41
New Publications
130
Language
Document type
No document type
207
Guidelines
57
Studies & Reports
45
Strategic & Response Plan
20
Manuals
18
Fact sheets
7
Training Material
5
Situation Updates
4
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
Ghana
14
Uganda
14
India
14
Western and Central Europe
13
Rwanda
11
Global
11
Eastern Europe
11
Nepal
10
South Africa
10
Namibia
9
Ethiopia
8
Sierra Leone
7
Malawi
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Africa
4
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
65
Policies
58
Policies & Guidelines HIV & TB
37
Guidelines
34
Studies & Reports
18
Women & Child Health
10
TB
10
Malaria
9
NTDs & Others
8
Statistics
6
Pharmacy & Technology
5
COVID-19
4
Countries
4
Non-communicable Diseases
4
HIV & STI
4
Disease Prevention & Control
4
Communicable Diseases
3
Hepatitis
3
Vaccine-preventable Diseases
3
Community Health
3
Capacity Building
3
Taeniasis/ Cysticercosis
2
Snakebites
2
Pharmaceutical Assessments
2
NCD
2
Medical Devices & Equipment
2
Immunization
2
General Guidelines
2
Leprosy
2
Paediatrics
1
Clinical Training
1
Rabies
1
Helminthiasis
1
Under-5 nutrition
1
Disaster Preparedness
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
Vector Control
1
Community Health
1
Pediatric cancer
1
Non-communicable Diseases NCD
1
Public Health
1
Pediatrics
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Other
1
Respiratory Infections
1
Communicable Diseases
1
Health Systems
1
Maternal Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Laboratory Quality Assurance
1
Key Resources
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
Country specific
15
Rational use of Medicine
11
Drug resistant TB
11
Access & Strategy
8
Pharmacovigilance
8
Reports & Studies
7
Essential Medicines
6
Falsified & Substandard
5
Traditional & Herbal Medicines
5
Antiretroviral Treatment ART
5
Clinical Aspects, Treatment & Prevention
4
Clinical Guidelines
4
Supporting tools
4
Country Specific
4
Immunization Guidelines
4
Eastern Europe & Central Asia
4
SEAR (South-east Asia Region)
4
Adults
3
Hospital Readiness/Essential Health Services
3
Inactivated COVID-19 Vaccines
3
Essential Medicines & Devices Lists
3
General Guidelines for Rational Use
3
Overview, Studies & Reports
3
Research & Access
3
Western & Central Europe
3
Treatment & Prevention
2
Preparedness, Response & Risk Communication
2
Prevention & Control
2
Children & Adolescents
2
WPRO (Western Pacific Region)
2
Children
2
Georgia
2
Drug resistance
2
Ethiopia
2
International
2
Prevention & Preparedness
2
Studies
2
General
2
Oxygen Therapy
2
Logistics & Supply
2
Prices and Patents
2
Pharmaceutical Assessments
2
Pharmacy Practice
2
One Health
2
Waste Managment
2
Studies & Reports
2
Education of students & professionals
2
Uganda
2
HIV service delivery
2
Reports & Studies
2
Eastern Europe and central Asia
2
Outbreak Prevention & Control
1
Clinical Guidelines
1
Childhood TB
1
Agriculture & Veterinary
1
Clinical Guidelines
1
Azerbaijan
1
Clinical Aspects
1
Vaccination
1
Ukraine
1
South Africa
1
Influenza
1
Treatment Guidelines HIV
1
Namibia
1
Public Health
1
HIV
1
Prevention & Control
1
Rwanda
1
Research
1
Vaccination
1
TB & Other Vulnerable Populations
1
Country Guidelines
1
Belarus
1
Reports
1
Russia
1
Health Personnel
1
Infection Control General
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Training, others
1
Appeals and Response Plans
1
Gender Aspects
1
Communication Material
1
TB/HIV
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Standard Operating Procedure (SOP)
1
Midwives
1
Pharmacy Management
1
Quality Assurance
1
Antimicrobial Resistance (AMR)
1
Waste management
1
Leishmaniasis
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Patient Safety
1
Clinical Aspects & Diagnosis
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
General Aspects
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Training
1
General Public
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Kazakhstan
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Kenya
1
Meningitis & Encephalitis
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
17–24 November 2015
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Pharmaceutical profile of DRC
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Framework for implementation.
The END TB Strategy.
